Portal de investigação
Optimal periprocedural antithrombotic treatment in carotid interventions: An international, multispecialty, expert review and position statement
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Participantes de fora da FMUP
- Paraskevas, KI
- Gloviczki, P
- Mikhailidis, DP
- Antignani, PL
- Dardik, A
- Eckstein, HH
- Faggioli, G
- Fernandes, JFE
- Fraedrich, G
- Gupta, A
- Jawien, A
- Jezovnik, MK
- Kakkos, SK
- Knoflach, M
- Lal, BK
- Lanza, G
- Liapis, CD
- Loftus, IM
- Millon, A
- Pini, R
- Poredos, P
- Proczka, R
- Ricco, JB
- Rundek, T
- Saba, L
- Schlachetzki, F
- Silvestrini, M
- Spinelli, F
- Stilo, F
- Suri, JS
- Zeebregts, CJ
- Lavie, CJ
- Chaturvedi, S
Unidades de investigação
Abstract
Background: The optimal antithrombotic (antiplatelet or anticoagulant) treatment of patients undergoing extracranial carotid artery interventions is a subject of debate. The aim of this multidisciplinary document was to critically reviewthe recommendations of current guidelines, taking into consideration the results of recently published studies. Methods: The various antithrombotic strategies reported were evaluated for asymptomatic and symptomatic patients undergoing extracranial carotid artery interventions (endarterectomy, transfemoral carotid artery stenting [CAS] or transcarotid artery revascularization [TCAR]). Based on a critical review, a series of recommendations were formulated by an international expert panel. Results: For asymptomatic patients, we recommend low-dose aspirin (75-100 mg/day) or clopidogrel (75 mg/day) with the primary goal to reduce the risk of myocardial infarction and cardiovascular event rates rather than to reduce the risk of stroke. For symptomatic patients, we recommend dual antiplatelet treatment (DAPT) initiatedwithin 24 h of the index event to reduce the risk of recurrent events. We suggest that following transfemoral CAS or TCAR, patients continue DAPT for 1 month after which a single antiplatelet agent is used. High level of evidence to support anticoagulant treatment for patients with carotid artery disease is lacking. Conclusions: The antithrombotic treatment offered to carotid patients should be individualized, taking into account the presence of symptoms, the type of intervention and the goal of the treatment. The duration and type of DAPT (ticagrelor instead of clopidogrel) should be evaluated in future trials. (c) 2022 Elsevier Inc. All rights reserved.
Copyright © 2022 Elsevier Inc. All rights reserved.
Dados da publicação
- ISSN/ISSNe:
- 1873-1740, 0033-0620
- Tipo:
- Review
- Páginas:
- 28-37
- Link para outro recurso:
- www.scopus.com
Progress in Cardiovascular Diseases W.B. Saunders Ltd
Citações Recebidas na Web of Science: 3
Citações Recebidas na Scopus: 4
Documentos
- Não há documentos
Filiações
Keywords
- Carotid endarterectomy; Carotid artery stenting; TCAR; Aspirin; Clopidogrel; Antithrombotic treatment; Stroke
Campos de estudo
Proyectos asociados
Endovascular Treatment of Aortic Arch Aneurysms
Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida
Estudo Clínico Académico (Aneurysms) . 2020
The role of infrared thermography in predicting diabetic foot outcomes
Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida
Estudo Clínico Académico (diabetic foot) . 2021
Endovascular solutions for type IA endoleak after endovascular aneurysm repair
Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida
Estudo Clínico Académico . 2021
Intermittent Claudication: Importance of Supervised Exercise Programme
Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida
Estudo Clínico Académico . 2021
Endovascular Aneurysm Repair - Strategies and Outcomes in Hostile Anatomies
Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida
Estudo Clínico Académico . 2022
Citar a publicação
Paraskevas KI,Gloviczki P,Mikhailidis DP,Antignani PL,Dardik A,Eckstein HH,Faggioli G,Fernandes J,Fraedrich G,Gupta A,Jawien A,Jezovnik MK,Kakkos SK,Knoflach M,Lal BK,Lanza G,Liapis CD,Loftus IM,Mansilha A,Millon A,Pini R,Poredos P,Proczka R,Ricco JB,Rundek T,Saba L,Schlachetzki F,Silvestrini M,Spinelli F,Stilo F,Suri JS,Zeebregts CJ,Lavie CJ,Chaturvedi S. Optimal periprocedural antithrombotic treatment in carotid interventions: An international, multispecialty, expert review and position statement. Prog. Cardiovasc. Dis. 2022. 74p. 28-37. IF:9,100. (1).
